![](/rp/kFAqShRrnkQMbH6NYLBYoJ3lq9s.png)
LATISSE™ Consent Form . LATISSE™ is approved by the Food and Drug Administration (FDA) for the treatment of thin or short eyelashes. If you have a history of glaucoma or abnormal intraocular pressure (IOP), you should inform Dr. or a staff member and should not use LATISSE™. Only use LATISSE™ with close supervision of your doctor.
Latisse is a prescription treatment approved by the FDA to grow longer, thicker, and darker eyelashes. Latisse is believed to affect the growth phase of the eyelash hair cycle in 2 ways; first, it increases the length of the “growth”
- [PDF]
LATISSE CONSENT
LATISSE CONSENT LATISSE by Allergan is a treatment for hypotrichosis (having inadequate or not enough eyelashes). This once daily prescription medication will enhance the length, thickness, and darkness of eyelashes in as little as eight weeks, with full results at sixteen weeks. Apply LATISSE once daily at night to the skin of the upper eyelid ...
Latisse® (bimatoprost ophthalmic solution 0.3%) is indicated for the correction of hypotrichosis (inadequate hair amount) of the upper eyelashes by increasing their growth including length, thickness, and darkness.
INFORMED CONSENT FOR LATISSE™ TREATMENT (Treatment for hypotrichosis) WHAT ARE THE INDICATIONS FOR LATISSE™ TREATMENT? Latisse™ is the brand name for bimatoprost, a sister medication already FDA approved for the treatment of glaucoma known as Lumigan®. LatisseTM is FDA approved for the treatment of hypotrichosis of the
LATISSE INFORMED CONSENT I, _____, understand that I will be given a prescription for Latisse (bimatoprost ophthalmic solution) which is indicated to treat hypotrichosis (inadequate or not enough eyelashes) of the eyelashes by increasing their …
LATISSE ® Consent Form LATISSE ® is a repackaging of bimatoprost, a prostaglandin medication sold as LUMIGAN ® since 2001 as a glaucoma medication. My intention I using LATISSE ® is solely for the cosmetic enhancement of eyelash length, thickness, and number.
LatisseTM Consent Form
Latisse™ is FDA approved for the treatment of the eyelashes by making them grow longer, thicker, and darker. The onset of action is gradual with most users seeing significant improvement in the length and number of lashes by 2 months.
LATISSE is an FDA-approved prescription treatment for hypotrichosis used to grow eyelashes, making them longer, thicker, and darker. Hypotrichosis is another name for having inadequate or not enough eyelashes.
I understand that Latisse is indicated to treat hypotrichosis of the eyelashes (short or not enough eyelashes). Latisse can increase their growth including length, thickness, and darkness.